The risk of osteoporotic fractures is higher in individuals with diabetes than those with no diabetes. However, the reason behind this cannot be explained precisely as presently it is not well-comprehended. In forthcoming research, the scientists from the Rensselaer Polytechnic Institute are supposed to employ advanced measurement methods and study the impact of Type 1 diabetes on bones and study how medicines can be used to minimize the fracture risks.
The Author of this study Deepak Vashishth stated, “We are studying the mechanisms of what would lead to such type of fragility.” While this research will be carried out in association with the Creighton University, it is supposed to be backed financially in the form of the National Institute of Diabetes and Digestive and Kidney Diseases’ new R01 grant. Vashishth stated that while the fractures cannot be completely explained or predicted with the help of existing clinical devices, such type of comprehension is vital at present. He added that this challenge becomes more critical as the impact of Type 1 diabetes on the bones of an individual is different than that of Type 2 diabetes.
Vashishth stated that Type 1 diabetic patients are at higher lifetime risk than those with Type 2 diabetes. In the latest study, the bone tissue samples of patients with Type 1 diabetes with age group over 50 Years will be gathered. To comprehend the impact of Type 1 diabetes on bone and how this impact makes bones vulnerable to breakdown, a novel protein-based approach—which is presently not employed for fracture diagnosis in clinics—will be used by the research team.
On a similar note, a recent study highlighted the probability of females to omit the suggested tests of cancers while they are managing chronic disease including diabetes. According to the results of researches carried out from the last 20 Years, diabetic females are less probable to carry out the screenings for breast, colorectal, and cervical cancers than those with no history of diabetes.
Sandra pursued Masters of Science in Microbiology and joined the healthnewsreports24.com platform at the early stage of her writing career. She is connected with our news portal for the last 9 Years and leads the Health Department efficiently. her strong management and leadership skills have helped her to execute all the duties precisely. she is writing on diverse topics from the Health domain—diverse trials, the introduction of new drugs, and latest researches & inventions, to name a few. At the same time, Sandra believes in offering quality services, which helps us to grow and maintain the number of readers on the healthnewsreports24.com platform.